financetom
Business
financetom
/
Business
/
Mastercard Insider Sold Shares Worth $4,072,170, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mastercard Insider Sold Shares Worth $4,072,170, According to a Recent SEC Filing
Jun 21, 2024 11:35 AM

02:05 PM EDT, 06/21/2024 (MT Newswires) -- Craig Vosburg, Chief Services Officer, on June 20, 2024, sold 9,028 shares in Mastercard ( MA ) for $4,072,170. Following the Form 4 filing with the SEC, Vosburg has control over a total of 58,940 shares of the company, with 58,940 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1141391/000114139124000124/xslF345X03/wk-form4_1718992632.xml

Price: 452.21, Change: -0.30, Percent Change: -0.07

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Broadcom Insider Sold Shares Worth $3,297,438, According to a Recent SEC Filing
Broadcom Insider Sold Shares Worth $3,297,438, According to a Recent SEC Filing
Apr 2, 2024
08:21 AM EDT, 04/02/2024 (MT Newswires) -- Mark David Brazeal, Chief Legal & Corp Affairs Ofc, on March 28, 2024, sold 2,500 shares in Broadcom ( AVGO ) for $3,297,438. Following the Form 4 filing with the SEC, Brazeal has control over a total of 46,974 shares of the company, with 46,974 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1730168/000173016824000037/xslF345X03/wk-form4_1712011025.xml Price: 1345.28,...
Cielo's controlling shareholders reach deal to lift tender offer price
Cielo's controlling shareholders reach deal to lift tender offer price
Apr 2, 2024
SAO PAULO, April 2 (Reuters) - The controlling shareholders of Brazilian payments firm Cielo have reached an agreement with some minority shareholders to raise the price of a tender offer to take the company private, according to a securities filing on Tuesday. Under the agreement, lenders Banco do Brasil and Bradesco have committed to raise the offer price to 5.60...
Verve Therapeutics Pauses Heart-1 Trial After Serious Adverse Events; Shares Fall Pre-Bell
Verve Therapeutics Pauses Heart-1 Trial After Serious Adverse Events; Shares Fall Pre-Bell
Apr 2, 2024
08:17 AM EDT, 04/02/2024 (MT Newswires) -- Verve Therapeutics ( VERV ) said Tuesday it paused enrollment for its Heart-1 phase 1b clinical trial after one of its dosed patients experienced serious adverse events. Shares of the company fell more than 34% in recent premarket activity on Tuesday. The Heart-1 trial is an open-label phase 1b trial designed to evaluate...
Avicanna's Q4 Loss Narrows, Revenue Grows
Avicanna's Q4 Loss Narrows, Revenue Grows
Apr 2, 2024
08:18 AM EDT, 04/02/2024 (MT Newswires) -- Avicanna Inc. ( AVCNF ) , a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, on Tuesday reported a fourth-quarter net comprehensive loss of $2.4 million, or $0.02 per share, narrower than a loss of $7.8 million, or $0.09 per share, a year earlier. Revenue for the quarter...
Copyright 2023-2026 - www.financetom.com All Rights Reserved